Recent Finacing
Recent Raise
Synthorx develops protein therapeutics using an expanded genetic alphabet and synthetic nucleotide chemistry to enable site-specific incorporation of noncanonical amino acids and engineers cytokines.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Synthorx.
